Skip to main content

JYSSBio Closes B+ Round for Single-Use Bioreactor Manufacturing

Zhejiang JYSS Bio-Engineering closed a B+ round led by Huatai International Private Equity Fund to expand its single use bioreactor and assemblies manufacturing. In 2014, JYSSBio was the first China company to offer single use bioreactors. In 2018, the company began large-scale manufacturing and entered the CDMO business. JYSSBio said it would use the proceeds to increase its manufacturing capacity expansion and make further R&D investments. The size of the financing was not disclosed. Mpre details.... Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.